Ulisse Biomed Spa
MIL:UBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Sanrio Co Ltd
OTC:SNROF
|
JP |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
Wal Mart de Mexico SAB de CV
BMV:WALMEX
|
MX |
|
C
|
Criteo SA
F:CI5A
|
FR |
|
N
|
National Vision Holdings Inc
F:7NV
|
US |
Wall St Price Targets
UBM Price Targets Summary
Ulisse Biomed Spa
According to Wall Street analysts, the average 1-year price target for
UBM is 1.3 EUR with a low forecast of 1.06 EUR and a high forecast of 1.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UBM's stock price target?
Price Target
1.3
EUR
According to Wall Street analysts, the average 1-year price target for
UBM is 1.3 EUR with a low forecast of 1.06 EUR and a high forecast of 1.56 EUR.
What is the Revenue forecast for Ulisse Biomed Spa?
Projected CAGR
68%
Over the last 5 years, the compound annual growth rate for Revenue has been 135%. The projected CAGR for the next 6 years is 68%.